Dr. Clapham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 North 1900 East, Room 4A100 SOM
Salt Lake City, UT 84132Phone+1 801-213-7505
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
- Harvard Medical SchoolClass of 2012
Certifications & Licensure
- UT State Medical License 2022 - 2026
- ID State Medical License 2023 - 2025
- WY State Medical License 2022 - 2025
- MA State Medical License 2020 - 2023
- CT State Medical License 2015 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 2 citationsJAK2-mutant clonal hematopoiesis is associated with venous thromboembolism.Rebecca L Zon, Aswin Sekar, Katharine Clapham, Ohad Oren, Abhishek Niroula
Blood. 2024-11-14 - 12 citationsBMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition.Heon-Woo Lee, Takaomi Adachi, Boryeong Pak, Saejeong Park, Xiaoyue Hu
Cardiovascular Research. 2023-05-02 - Venous Thromboembolism Polygenic Risk Score Associates With Pulmonary Hypertension in the UK Biobank.Katharine R Clapham, Md Mesbah Uddin, Michael C Honigberg, Thomas Gilliland, Yunfeng Ruan
Circulation. Genomic and Precision Medicine. 2022-12-01
Press Mentions
- Katharine Clapham, MD - Phaware® Interview 416May 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: